SCHEMBL4859288

SCHEMBL4859288

O=C1c2ccc3c4cccc5cccc(c6ccc(c2c36)C(=O)N1C1CCCCC1)c54

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.47
KDM4E B2RXH2 2/20 0.42
HPGD P15428 2/20 0.42
HSD17B10 Q99714 2/20 0.42
ATM Q13315 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
TERT O14746 1/20 0.41
CYP1B1 Q16678 2/20 0.41
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40
MAPK1 P28482 1/20 0.40
POLB P06746 1/20 0.38
ADRB2 P07550 1/20 0.38
ADRB1 P08588 1/20 0.38
ADRB3 P13945 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8877707 1.00 ALDH1A1 (0.47) ALDH1A1KDM4EHPGDHSD17B10ATM
SCHEMBL8877927 1.00 ALDH1A1 (0.47) ALDH1A1KDM4EHPGDHSD17B10ATM
SCHEMBL8878000 1.00 ALDH1A1 (0.47) ALDH1A1KDM4EHPGDHSD17B10ATM
SCHEMBL8880293 0.98 ALDH1A1 (0.44) ALDH1A1KDM4EHPGDHSD17B10ATM
SCHEMBL2861936 0.89 ALDH1A1 (0.51) ALDH1A1KDM4EHPGDHSD17B10ATM
SCHEMBL6266985 0.89 ALDH1A1 (0.51) ALDH1A1KDM4EHPGDHSD17B10ATM
SCHEMBL822758 0.87 ALDH1A1 (0.49) ALDH1A1KDM4EHPGDHSD17B10ATM
SCHEMBL7646919 0.85 KEAP1 (0.48) ALDH1A1KDM4EATMSMN1; SMN2NPSR1
SCHEMBL7646895 0.85 CYP1B1 (0.56) ALDH1A1KDM4EHPGDHSD17B10ATM
SCHEMBL13001996 0.84 ALDH1A1 (0.48) ALDH1A1KDM4EHPGDHSD17B10ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7358362-B2 Method for the production of terylene-3,4:11,12-tetracarboxydiimides by direct synthesis BASF AKTIENGESELLSCHAFT (DE) 2008-04-15 US disclosed
US-20070155968-A1 Method for the production of terylene-3,4:11,12-tetracarboxydiimides by direct synthesis BASF AKTIENGESELLSCHAFT (DE) 2007-07-05 US disclosed
US-6486319-B1 Thermochromic rylene dyes BASF AKTIENGESELLSCHAFT (DE) 2002-11-26 US disclosed
US-5650513-A Process for preparing perylene-3,4-dicarboxylic acid derivatives, the derivatives thus prepared and their use CIBA-GEIGY CORPORATION (US) 1997-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155968-A1 Method for the production of terylene-3,4:11,12-tetracarboxydiimides by direct synthesis HACL2, HRH3, HCN2 ALDH1A1 3629/4885KDM4E 2657/4885HPGD 1301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.